The term hemangioma refers to the common tumor of infancy that exhibits rapid postnatal growth and slow regression during childhood. 1 Hemangioma is the most common tumor in infancy, with a perinatal incidence of 1%-3% and affecting 10% of infants by one year of age. 2 Up to 30% of preterm infants with low birth weight (1,000 g) may have hemangioma. A predilection for the female sex has been reported, with a ratio of 2-5:1. 3, 4 The initial sign of hemangioma is either an erythematous macular patch, a blanched spot, or a localized telangiectasia, surrounded by a pale halo. 5 The hallmark of hemangiomas is rapid growth during the first several understanding and treatment of these vascular lesions. Previous complacency in treatment is changing to a more proactive approach to circumvent immanent esthetic sequelae. 9 Anatomic location, lesion size, and patient age are three important drivers in the decision of whether to intervene. A nickel-size lesion on the tip of a newborn nose poses a different problem from the same lesion located at the base of the occiput; a 3-cm hemangioma in a perineal fold is more likely to ulcerate and become infected than an identical subclavicular lesion. Similarly, the size or footprint of the hemangioma impacts the decision of whether to intervene. Many parents will tolerate a 3-mm bright red spot on their child's forehead, but few will accept a 3-cm lesion in the same location. Patient age is another factor that affects the decision of whether to intervene. It may be reasonable to observe a 3-month-old child with a hemangioma, whereas the same lesion might best be resected in a 13-month-old child to achieve the best aesthetic outcome. 10 A number of treatment modalities are available for the management of hemangiomas. These include observation, corticosteroids (systemic, intralesional), sclerotherapy, interferon _2α, laser therapy, vincristine, Beta-blockers,and surgical treatment. 11 The aim of this study was to identify those lesions that are most likely to require treatment and how to select the treatment modality that is best suited for a particular individual with emphasis on the timing of intervention, particularly focusing on outcomes following various managements (steroid or surgical treatment), to enable plastic and maxillofacial surgeon to develop an approach in the management of these esthetically, functionally, and psychosocially compromising congenital vascular tumor. 9 of observation, steroid, surgical excision or combined therapy. Observation selected for silent small, localized hemangioma that do not involve aesthetically or functionally important areas. Infants were followed closely, on a monthly basis. Steroids were recommended for children up to the age of 18-20 months, i.e., during the proliferative phase of hemangiomas. Intralesional injection of triamcinolone acetonide (3 to 5 mg/ kg per procedure) was advised for focal hemangiomas and those causing obstruction of orifices such as periorbital hemangiomas. The injection should be with low injection pressure and no digital pressure after the procedure. The injections were repeated at monthly intervals to evaluate the response. Usually three to five injections were needed and were terminated when no further response in treatment was noticed. Oral corticosteroids in the form of prednisolone were recommended for rapidly proliferating large hemangiomas at an initial dose of 4 mg/kg body weight. The hemangiomas were reevaluated for steroid response after a week. If change in size of hemangioma was evident at that time, the treatment was maintained at the initial dose for three more weeks and then tapered over a period of 4-8 weeks. The patients were then followed at monthly intervals to evaluate the response and discontinued by 10 to 11 months. Surgical excision was recommended mainly for
Methods

Design and sample collection:
This is a prospective study conducted in Erbil City, Kurdistan Region, Iraq in the Department of Plastic and Reconstruction involuted hemangiomas, and sometimes for proliferative hemangiomas. In proliferative phase, excision was advised for steroid nonresponders, periorbital hemangiomas, and ulcerated hemangiomas. Reconstruction of defect after excision of hemangioma was carried out by primary closure, or local flaps. The distribution of hemangioma is shown in Table 1 . Lip was the most common site.
Patients were followed up to analyze the post-treatment outcome based on the improvement in size and color of the hemangioma. The follow up findings were reported and analyzed, photographs have been taken for all patients in each visits. Treatment outcomes were assessed by three raters, including two physicians and one patient or patient's parents, and were graded as poor (score 0), fair (score 1), good (score 2), and excellent (score 3). The average of individual scores given by each rater was taken. Percentage improvement for each patient was calculated using the following scale: 1) minimal improvement (0%-25%); 2) mild improvement (26%-50%); 3) moderate improvement (51%-75%); and 4) excellent improvement (76%-100%). Results of each of these parameters were summarized by groups.
Results
The age of the patients at the time of initial consultation ranged from one month to thirteen years, the mean age was three years. The hemangiomas arose within the 1 st month after birth in 76% of patients. The gender distribution was 70 female and 34 male. The complications presented during initial consultation and their management are shown in Surgical excision was carried out for management of hemangiomas in 32 patients ( Table 2 ). The final results of each of the treatment group are summarized in Table 3 . Table 3 shows statistically significant difference among the groups regarding improvement in size and color of hemangioma (P <0.01). Surgical treatment was better compared with steroid therapy. 
Discussion
Hemangiomas are a group of pediatric vascular tumors usually appearing soon after birth in 60%-70% of patients. 12 This was evident in the present study also, as the hemangiomas arose within the 1 st month after birth in 76% of patients. The ratio of female to male in our group of patients was 2:1, which was similar to the ratio generally reported in the literature of 2-5:1. 10, 12, 13 The management of hemangiomas has been a subject of intense controversy for many decades. They are remarkably heterogeneous regarding size, location, and rate of growth and involution. Despite the benign and trivial nature of most hemangiomas, a significant minority cause functional compromise or permanent disfigurement. They are also notoriously unpredictable early in infancy because some barely grow whereas others blossom forth into huge tumors.
14, 15 We therefore undertook a review of our patients to evaluate the treatment outcomes following various managements of hemangiomas, remembering that the comparison of ways of treatment is significant when all variables are fixed (size, site, age). Our study revealed a favorable outcome after steroid therapy regarding to reduction in size of tumor, and improvement in color. The age of the patients in this group ranged from three months to one and half year. Thus, steroids form the mainstay of treatment of hemangiomas during the proliferative phase, 9 with intralesional therapy for localized and periorbital hemangiomas 16, 17 and systemic therapy for large and diffusel hemangiomas 17, 18 ( Figure 1 and 2) . a c b Combined modality approach for the management of significantly large hemangiomas also resulted in an improved outcome in a majority of patients (80% moderate to excellent improvement), with steroids and surgical excision (Figure 4) . Studies by Achauer et al, 14 Demiri et al 19 and Kane et al, 20 also showed improved outcome with combined treatment approach. Thus, significantly large and problematic hemangiomas can be managed with a combination of medical and surgical treatment modalities. The present study demonstrated a large non-treatment rate of complications at initial consultation of 47% (49 patients), which can be attributed to the fact that these patients seek treatment after complications had developed. However, this large rate warrants the need for awareness through community based camps and other measures regarding the need for intervention. Fibrofatty masses of tissue were observed in 11 patients (10.5%). This concluded the observation that hemangiomas, if allowed to involute, leave excess fibrofatty skin residium. 8, 21 Obstruction of orifices was present in 15 patients (14%), ulceration in 17 patients (16%), bleeding in 5 patients(4.8%) and infection occurred in one patient (0.9%). Thus, it can be concluded that obstruction and ulceration are the most common indications for management of hemangiomas during the proliferative phase. 9, 21 Comparison of treatment outcomes between treatment groups revealed that there was significant difference in outcome among various treatment groups. This can be explained on the basis that surgical excision and combined approach eliminated hemangioma more completely. In the present study we emphasize that an early diagnosis and active intervention is important, because these lesions initially presenting as a macular rash can grow rapidly to cause functional compromise, and if left untreated they leave a residue resulting in an esthetic compromise.
